Pfizer, J&J, Merck evaluating technologies for Zika vaccine

Feb 3 (Reuters) - Pfizer Inc, Johnson and Johnson and Merck & Co Inc said they were evaluating their technologies or existing vaccines for their potential to combat Zika, a rapidly spreading mosquito-borne disease linked to birth defects.